Cite

Copy

Chapter menu

Show all

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Add to Home Screen/Install App' to create a shortcut app

ISPN GuideVascular Disorders of the Nervous System in ChildrenIschemic Cerebrovascular Disease in Children HomepageReferences for Ischemic Cerebrovascular Disease in Children

References for Ischemic Cerebrovascular Disease in Children

This page was last updated on January 7th, 2025

  1. Willis T. Pathologiae Cerebri, et Nervosi Generis Specimen: In Quo Agitur de Morbis Convulsivis, et de Scorbuto. Apud Danielem Elzevirium; 1667.
  2. Freud S, Rie O. Klinische Studie Über Die Halbseitige Cerebrallähmung Der Kinder. Perles; 1891.
  3. Sachs B, Peterson F. A study of cerebral palsies of early life, based upon an analysis of one hundred and forty cases. J Nerv Ment Dis. 1890;15(5):295.
  4. Osler W. Cerebral Palsies of Children. Mac Keith Press; 1889.
  5. Ford FR, Schaffer AJ. The etiology of infantile acquired hemiplegia. Arch Neurol Psychiatry. 1927;18(3):323-347. doi:10.1001/archneurpsyc.1927.02210030003001
  6. Ford F. Diseases of the Nervous System in Infancy, Childhood, and Adolescence. 1st ed. Charles C Thomas; 1937.
  7. Banker BQ. Cerebral vascular disease in infancy and childhood. 1. Occlusive vascular diseases. J Neuropathol Exp Neurol. 1961;20:127-140. doi:10.1097/00005072-196101000-00008
  8. Wisoff HS, Rothballer AB. Cerebral arterial thrombosis in children: review of literature and addition of two cases in apparently healthy children. Arch Neurol. 1961;4(3):258-267. doi:10.1001/archneur.1961.00450090024004
  9. Byers RK, McLean WT. Etiology and course of certain hemiplegias with aphasia in childhood. Pediatrics. 1962;29(3):376-383. doi:10.1542/peds.29.3.376
  10. deVeber GA, Kirton A, Booth FA, et al. Epidemiology and outcomes of arterial ischemic stroke in children: The Canadian Pediatric Ischemic Stroke Registry. Pediatr Neurol. 2017;69:58-70. doi:10.1016/j.pediatrneurol.2017.01.016
  11. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998;19(1):110-129. doi:10.1016/s0197-2456(97)00099-8
  12. Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39(9):2644-2691. doi:10.1161/STROKEAHA.108.189696
  13. Roach ES, Lo WD, Heyer GL. Pediatric Stroke and Cerebrovascular Disorders. Demos Medical Publishing; 2011.
  14. Barnes C, Deveber G. Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res. 2006;118(1):67-74. doi:10.1016/j.thromres.2005.05.021
  15. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90(3):1004-1008. doi:10.1073/pnas.90.3.1004
  16. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-113. doi:10.1038/ng0595-111
  17. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88(10):3698-3703.
  18. van der Put NM, Gabreëls F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62(5):1044-1051. doi:10.1086/301825
  19. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64(3):169-172. doi:10.1006/mgme.1998.2714
  20. Steinlin M. A clinical approach to arterial ischemic childhood stroke: increasing knowledge over the last decade. Neuropediatrics. 2012;43(1):1-9. doi:10.1055/s-0032-1307449
  21. Bernard TJ, Manco-Johnson MJ, Goldenberg NA. The roles of anatomic factors, thrombophilia, and antithrombotic therapies in childhood-onset arterial ischemic stroke. Thromb Res. 2011;127(1):6-12. doi:10.1016/j.thromres.2010.09.014
  22. Sydenstricked VP, Mulherin WA, Houseal RW. Sickle cell anemia: report of two cases in children, with necropsy in one case. Am J Dis Child. 1923;26(2):132–154. doi:10.1001/archpedi.1923.04120140031004
  23. Smith ER, Scott RM. Moyamoya: epidemiology, presentation, and diagnosis. Neurosurg Clin N Am. 2010;21(3):543-551. doi:10.1016/j.nec.2010.03.007
  24. Stockman JA, Nigro MA, Mishkin MM, et al. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 1972;287(17):846-849. doi:10.1056/NEJM197210262871703
  25. Hunter A, Lipscomb JM. Congenital pulmonary atresia with cerebral thrombosis and hemiplegia. Br Heart J. 1942;4(4):124-130. doi:10.1136/hrt.4.4.124
  26. Berthrong M, Sabiston DC Jr. Cerebral lesions in congenital heart disease, a review of autopsies on 162 cases. Bull Johns Hopkins Hosp. 1951;89(5):384-406.
  27. Gerritsen T, Vaughn JG, Waisman HA. The identification of homocystine in the urine. Biochem Biophys Res Commun. 1962;9:493-496. doi:10.1016/0006-291x(62)90114-6
  28. Carson NA, Neill DW. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child. 1962;37(195):505-513. doi:10.1136/adc.37.195.505
  29. Schimke RN, McKusick VA, Huang T, et al. Homocystinuria. Studies of 20 families with 38 affected members. JAMA. 1965;193:711-719. doi:10.1001/jama.1965.03090090017003
  30. Carson NA, Dent CE, Field CM, et al. Homocystinuria: clinical and pathological review of ten cases. J Pediatr. 1965;66:565-583. doi:10.1016/s0022-3476(65)80121-4
  31. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16(4):481-488. doi:10.1002/ana.410160409
  32. Fabry J. Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae). Archiv für Dermatologie und Syphilis. 1898;43(1):187-200.
  33. Anderson W. A case of “angeio-keratoma.” British Journal of Dermatology. 1898;10(4):113-117.
  34. Giacomini PS, Shannon PT, Clarke JT, et al. Fabry’s disease presenting as stroke in a young female. Can J Neurol Sci. 2004;31(1):112-114. doi:10.1017/s0317167100002936
  35. Rolfs A, Böttcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study [published correction appears in Lancet. 2006 Dec 23;368(9554):2210]. Lancet. 2005;366(9499):1794-1796. doi:10.1016/S0140-6736(05)67635-0
  36. Sims K, Politei J, Banikazemi M, et al. Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke. 2009;40(3):788-794. doi:10.1161/STROKEAHA.108.526293
  37. Cornet MC, Grose C, Vexler Z, et al. The role of infection and inflammation in the pathogenesis of pediatric arterial ischemic stroke. Semin Pediatr Neurol. 2022;44:100995. doi:10.1016/j.spen.2022.100995
  38. Marie P. Hémiplégie cérébrale infantile et maladies infectieuses. Prog Med. 1885;2:167.
  39. Thery F, Martina L, Asselman C, et al. Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity. Nat Commun. 2021;12(1):5772. doi:10.1038/s41467-021-26061-w
  40. Dratz HM, Woodhall B. Traumatic dissecting aneurysm of left internal carotid, anterior cerebral and middle cerebral arteries. J Neuropathol Exp Neurol. 1947;6(3):286-291. doi:10.1097/00005072-194707000-00009
  41. Anderson RM, Schechter MM. A case of spontaneous dissecting aneurysm of the internal carotid artery. J Neurol Neurosurg Psychiatry. 1959;22(3):195-201. doi:10.1136/jnnp.22.3.195
  42. de Bray JM, Baumgartner RW. History of spontaneous dissection of the cervical carotid artery. Arch Neurol. 2005;62(7):1168-1170. doi:10.1001/archneur.62.7.1168
  43. Carette S. Vasculitis: What have we learned in the last 50 years? J Rheumatol. 2022;49(7):848-852. doi:10.3899/jrheum.220207
  44. Younger DS. Stroke due to vasculitis in children and adults. Neurol Clin. 2019;37(2):279-302. doi:10.1016/j.ncl.2019.01.004
  45. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology. 1997;49(6):1541-1545. doi:10.1212/wnl.49.6.1541
  46. Ribes F. Exposé Succinct Des Recherches Faites Sur La Phlébite. Gueffier; 1825.
  47. Symonds CP. Cerebral thrombophlebitis. Br Med J. 1940;2(4158):348-352.
  48. Stansfield FR. Puerperal cerebral thrombophlebitis treated by heparin. Br Med J. 1942;1(4239):436-438.
  49. Ray BS, Dunbar HS, Dotter CT. Dural sinus venography as an aid to diagnosis in intracranial disease. J Neurosurg. 1951;8(1):23-37. doi:10.3171/jns.1951.8.1.0023
  50. Ray BS, Dunbar HS. Thrombosis of the dural venous sinuses as a cause of “pseudotumor cerebri.” Ann Surg. 1951;134(3):376-386.
  51. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis. Stroke. 2004;35(3):664-670. doi:10.1161/01.STR.0000117571.76197.26
  52. Einhäupl K, Bousser MG, De Bruijn SFTM, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13(6):553-559. doi:10.1111/j.1468-1331.2006.01398.x
  53. Moniz E. L’encephalographie artrielle, son importance dans la localization des tumeurs cerebrales. Rev Neurol. 1927;2:72-90.
  54. Moniz E. Trombores de Carótida Interna de Etiologia Traumática. 1948.
  55. Hounsfield GN. Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol. 1973;46(552):1016-1022. doi:10.1259/0007-1285-46-552-1016
  56. Rothner AD, Cruse RP, Horwitz SJ, et al. Computed tomographic findings in childhood hemiplegia. Cleve Clin Q. 1978;45(2):219-223. doi:10.3949/ccjm.45.2.219
  57. Segall HD, Ahmadi J, McComb JG, et al. Computed tomographic observations pertinent to intracranial venous thrombotic and occlusive disease in childhood. State of the art, some new data, and hypotheses. Radiology. 1982;143(2):441-449. doi:10.1148/radiology.143.2.7071346
  58. Geva T. Magnetic Resonance imaging: historical perspective. J Cardiovasc Magn Reson. 2006;8(4):573-580. doi:10.1080/10976640600755302
  59. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1588. doi:10.1056/NEJM199512143332401
  60. Chapman SN, Mehndiratta P, Johansen MC, et al. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag. 2014;10:75-87. doi:10.2147/VHRM.S39213
  61. Rivkin MJ, deVeber G, Ichord RN, et al. Thrombolysis in Pediatric Stroke Study. Stroke. 2015;46(3):880-885. doi:10.1161/STROKEAHA.114.008210
  62. Ferriero DM, Fullerton HJ, Bernard TJ, et al. Management of stroke in neonates and children: A scientific statement from the American Heart Association/American Stroke Association. Stroke. 2019;50(3):e51-e96. doi:10.1161/STR.0000000000000183
  63. Burgos AM, Saver JL. Evidence that tenecteplase Is noninferior to alteplase for acute ischemic stroke. Stroke. 2019;50(8):2156-2162. doi:10.1161/STROKEAHA.119.025080
  64. Jay CRG, Duncan AN, Ellika SK, et al. Stents for progressively symptomatic paediatric intracranial arterial dissection. J NeuroInterventional Surg. 2023;15(3):e3-e3. doi:10.1136/neurintsurg-2021-017464.rep
  65. Sun LR, Harrar D, Drocton G, et al. Endovascular therapy for acute stroke in children: age and size technical limitations. J Neurointerventional Surg. 2021;13(9):794-798. doi:10.1136/neurintsurg-2021-017311
  66. Oushy S, Garton A, Orbach DB, et al. Low-profile mechanical thrombectomy devices for large vessel occlusion in pediatric ischemic stroke. J Neurointerventional Surg. Published online May 6, 2024:jnis-2024-021574. doi:10.1136/jnis-2024-021574
  67. Franchini M, Liumbruno GM, Bonfanti C, et al. The evolution of anticoagulant therapy. Blood Transfus. 2016;14(2):175-184. doi:10.2450/2015.0096-15
  68. Jaffray J, Young G. Direct oral anticoagulants for use in paediatrics. Lancet Child Adolesc Health. 2022;6(3):207-214. doi:10.1016/S2352-4642(21)00343-6
  69. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5-11. doi:10.1056/NEJM199807023390102
  70. Adams RJ, Nichols FT, Figueroa R, et al. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992;23(8):1073-1077. doi:10.1161/01.STR.23.8.1073
  71. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997;42(5):699-704. doi:10.1002/ana.410420505
  72. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605-610. doi:10.1056/NEJM199202273260905
  73. DeBaun MR, Jordan LC, King AA, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020;4(8):1554-1588. doi:10.1182/bloodadvances.2019001142
  74. Edler I, Hertz CH. The use of ultrasonic reflectoscope for the continuous recording of the movements of heart walls. 1954. Clin Physiol Funct Imaging. 2004;24(3):118-136. doi:10.1111/j.1475-097X.2004.00539.x
  75. Hill JD. John H. Gibbon, Jr. Part I. The development of the first successful heart-lung machine. Ann Thorac Surg. 1982;34(3):337-341. doi:10.1016/s0003-4975(10)62507-6
  76. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976;235(23):2506-2509.
  77. Rimoin DL, Hirschhorn K. A history of medical genetics in pediatrics. Pediatr Res. 2004;56(1):150-159. doi:10.1203/01.PDR.0000129659.32875.84
  78. Ilinca A, Samuelsson S, Piccinelli P, et al. A stroke gene panel for whole-exome sequencing. Eur J Hum Genet. 2019;27(2):317-324. doi:10.1038/s41431-018-0274-4
  79. Lee SK, Kim SD, Kim SH, et al. Decompressive hemicraniectomy and duroplasty in toddlers and preschool children with refractory intracranial hypertension after unilateral hemispheric stroke. J Korean Neurosurg Soc. 2012;51(2):86-90. doi:10.3340/jkns.2012.51.2.86
  80. Kocher T. Hirnerschütterung, Hirndruck Und Chirurgische Eingriffe Bei Hirnkrankheiten. Vol 3. Hölder; 1901.
  81. Morgan MK, Sekhon LHS. Extracranial-intracranial saphenous vein bypass for carotid or vertebral artery dissections: a report of six cases. J Neurosurg. 1994;80(2):237-246. doi:10.3171/jns.1994.80.2.0237
  82. Schievink WI, Piepgras DG, McCaffrey TV, et al. Surgical treatment of extracranial internal carotid artery dissecting aneurysms. Neurosurgery. 1994;35(5):809.
  83. Smith ER, McClain CD, Heeney M, et al. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus. 2009;26(4):E10. doi:10.3171/2009.01.FOCUS08307
  84. Aldana PR, Hanel RA, Piatt J, et al. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study. Pediatr Blood Cancer. 2023;70(7):e30336. doi:10.1002/pbc.30336
  85. Reis CV, Safavi-Abbasi S, Zabramski JM, et al. The history of neurosurgical procedures for moyamoya disease. Neurosurg Focus. 2006;20(6):E7. Published 2006 Jun 15. doi:10.3171/foc.2006.20.6.7
  86. Marks MP, Dake MD, Steinberg GK, et al. Stent placement for arterial and venous cerebrovascular disease: preliminary experience. Radiology. 1994;191(2):441-446. doi:10.1148/radiology.191.2.8153318
  87. Price RF, Sellar R, Leung C, et al. Traumatic vertebral arterial dissection and vertebrobasilar arterial thrombosis successfully treated with endovascular thrombolysis and stenting. AJNR Am J Neuroradiol. 1998;19(9):1677-1680.
  88. Chern JJ, Chamoun RB, Mawad ME, et al. Endovascular stenting of traumatic extracranial carotid artery dissections in the pediatric population: a case report. Cases J. 2009;2:171. doi:10.1186/1757-1626-2-171
  89. Stence NV, Fenton LZ, Goldenberg NA, et al. Craniocervical arterial dissection in children: diagnosis and treatment. Curr Treat Options Neurol. 2011;13(6):636-648. doi:10.1007/s11940-011-0149-2
  90. Hoving JW, Marquering HA, Majoie CBLM. Endovascular treatment in patients with carotid artery dissection and intracranial occlusion: a systematic review. Neuroradiology. 2017;59(7):641-647. doi:10.1007/s00234-017-1850-y
  91. Goyal M, Fladt J, Coutinho JM, et al. Endovascular treatment for cerebral venous thrombosis: current status, challenges, and opportunities. J Neurointerv Surg. 2022;14(8):788-793. doi:10.1136/neurintsurg-2021-018101
  92. Sporns PB, Sträter R, Minnerup J, et al. Feasibility, safety, and outcome of endovascular recanalization in childhood stroke: The Save ChildS Study. JAMA Neurol. 2020;77(1):25-34. doi:10.1001/jamaneurol.2019.3403
  93. Satti S, Chen J, Sivapatham T, et al. Mechanical thrombectomy for pediatric acute ischemic stroke: review of the literature. J NeuroInterventional Surg. 2017;9(8):732-737. doi:10.1136/neurintsurg-2016-012320
  94. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;51(1):169-176. doi:10.1212/wnl.51.1.169
  95. Tuckuviene R, Christensen AL, Helgestad J, et al. Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994-2006: a nationwide population-based study. Acta Paediatr Oslo Nor 1992. 2011;100(4):543-549. doi:10.1111/j.1651-2227.2010.02100.x
  96. Giroud M, Lemesle M, Gouyon JB, et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48(11):1343-1348. doi:10.1016/0895-4356(95)00039-9
  97. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28(8):763-768. doi:10.1212/wnl.28.8.763
  98. Raju TNK, Nelson KB, Ferriero D, et al. Ischemic perinatal stroke: summary of a workshop sponsored by the National Institute of Child Health and Human Development and the National Institute of Neurological Disorders and Stroke. Pediatrics. 2007;120(3):609-616. doi:10.1542/peds.2007-0336
  99. Kenet G, Lütkhoff LK, Albisetti M, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children. Circulation. 2010;121(16):1838-1847. doi:10.1161/CIRCULATIONAHA.109.913673
  100. Hoffman JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890-1900. doi:10.1016/S0735-1097(02)01886-7
  101. Van Der Linde D, Konings EEM, Slager MA, et al. Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 2011;58(21):2241-2247. doi:10.1016/j.jacc.2011.08.025
  102. Mandalenakis Z, Rosengren A, Lappas G, et al. Ischemic stroke in children and young adults with congenital heart disease. J Am Heart Assoc. 2016;5(2):e003071. doi:10.1161/JAHA.115.003071
  103. Mackay MT, Wiznitzer M, Benedict SL, et al. Arterial ischemic stroke risk factors: The international pediatric stroke study. Ann Neurol. 2011;69(1):130-140. doi:10.1002/ana.22224
  104. Sacharow SJ, Picker JD, Levy HL. Homocystinuria caused by cystathionine beta-synthase deficiency. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews®. University of Washington, Seattle; 2017. Accessed July 2, 2024. http://www.ncbi.nlm.nih.gov/books/NBK1524/
  105. Klingelhöfer D, Braun M, Seeger-Zybok RK, et al. Global research on Fabry’s disease: Demands for a rare disease. Mol Genet Genomic Med. 2020;8(9):e1163. doi:10.1002/mgg3.1163
  106. Uusimaa J, Moilanen JS, Vainionpää L, et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann Neurol. 2007;62(3):278-287. doi:10.1002/ana.21196
  107. Moraitis E, Ganesan V. Childhood infections and trauma as risk factors for stroke. Curr Cardiol Rep. 2014;16(9):527. doi:10.1007/s11886-014-0527-y
  108. Nash M, Rafay MF. Craniocervical arterial dissection in children: pathophysiology and management. Pediatr Neurol. 2019;95:9-18. doi:10.1016/j.pediatrneurol.2019.01.020
  109. deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345(6):417-423. doi:10.1056/NEJM200108093450604
  110. Oleske DM, Cheng X, Jeong A, et al. Pediatric acute ischemic stroke by age-group: a systematic review and meta-analysis of published studies and hospitalization records. Neuroepidemiology. 2021;55(5):331-341. doi:10.1159/000518281
  111. Kim Y, Kim SY. Antiphospholipid antibody and recurrent ischemic stroke. Stroke. 2020;51(12):3728-3732. doi:10.1161/STROKEAHA.120.030431
  112. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294.
  113. Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114(25):5117-5125. doi:10.1182/blood-2009-05-220921
  114. Asakai H, Cardamone M, Hutchinson D, et al. Arterial ischemic stroke in children with cardiac disease. Neurology. 2015;85(23):2053-2059. doi:10.1212/WNL.0000000000002036
  115. Tabarki B, Hakami W, Alkhuraish N, et al. Inherited metabolic causes of stroke in children: mechanisms, types, and management. Front Neurol. 2021;12:633119. doi:10.3389/fneur.2021.633119
  116. Pia S, Lui F. Melas syndrome. In: StatPearls. StatPearls Publishing; 2024. Accessed July 2, 2024. http://www.ncbi.nlm.nih.gov/books/NBK532959/
  117. Fullerton HJ, Hills NK, Elkind MSV, et al. Infection, vaccination, and childhood arterial ischemic stroke. Neurology. 2015;85(17):1459-1466. doi:10.1212/WNL.0000000000002065
  118. Golomb MR, Fullerton HJ, Nowak-Gottl U, et al. Male predominance in childhood ischemic stroke: findings from the international pediatric stroke study. Stroke. 2009;40(1):52-57. doi:10.1161/STROKEAHA.108.521203
  119. Madison JA, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome. Eur J Rheumatol. 2020;7(Suppl 1):S3-S12. doi:10.5152/eurjrheum.2019.19160
  120. Truglia S, Capozzi A, Mancuso S, et al. Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome. Front Immunol. 2022;13:932181. doi:10.3389/fimmu.2022.932181
  121. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality In sickle cell disease — life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644. doi:10.1056/NEJM199406093302303
  122. Deegan PB, Bähner F, Barba M, et al. Fabry disease in females: clinical characteristics and effects of enzyme replacement therapy. In: Mehta A, Beck M, Sunder-Plassmann G, eds. Fabry Disease: Perspectives from 5 Years of FOS. Oxford PharmaGenesis; 2006. Accessed July 2, 2024. http://www.ncbi.nlm.nih.gov/books/NBK11591/
  123. Mehta A, Hughes DA. Fabry disease. In: Adam MP, Feldman J, Mirzaa GM, et al., eds. GeneReviews®. University of Washington, Seattle; 2024. Accessed July 2, 2024. http://www.ncbi.nlm.nih.gov/books/NBK1292/
  124. Porritt RA, Markman JL, Maruyama D, et al. IL-1-mediated sex differences in Kawasaki Disease vasculitis development and response to treatment. Arterioscler Thromb Vasc Biol. 2020;40(3):802-818. doi:10.1161/ATVBAHA.119.313863
  125. Lawee D. Atypical clinical course of Henoch-Schönlein purpura. Can Fam Physician. 2008;54(8):1117-1120.
  126. Twilt M, Benseler SM. The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol. 2011;8(2):97-107. doi:10.1038/nrrheum.2011.197
  127. Berfelo FJ, Kersbergen KJ, van Ommen CHH, et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke. 2010;41(7):1382-1388. doi:10.1161/STROKEAHA.110.583542
  128. Golomb MR, Dick PT, MacGregor DL, et al. Neonatal arterial ischemic stroke and cerebral sinovenous thrombosis are more commonly diagnosed in boys. J Child Neurol. 2004;19(7):493-497. doi:10.1177/08830738040190070301
  129. Fullerton HJ, Elkins JS, Johnston SC. Pediatric Stroke Belt: geographic variation in stroke mortality in US children. Stroke. 2004;35(7):1570-1573. doi:10.1161/01.STR.0000130514.21773.95
  130. Naughten ER, Yap S, Mayne PD. Newborn screening for homocystinuria: Irish and world experience. Eur J Pediatr. 1998;157(2):S84-S87. doi:10.1007/PL00014310
  131. Zschocke J, Kebbewar M, Gan-Schreier H, et al. Molecular neonatal screening for homocystinuria in the Qatari population. Hum Mutat. 2009;30(6):1021-1022. doi:10.1002/humu.20994
  132. Gupta N, Hiremath SB, Aviv RI, et al. Childhood cerebral vasculitis. Clin Neuroradiol. 2023;33(1):5-20. doi:10.1007/s00062-022-01185-8
  133. Adams RJ, Kutlar A, McKie V, et al. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994;45(4):279-282. doi:10.1002/ajh.2830450402
  134. Dlamini N, Billinghurst L, Kirkham FJ. Cerebral venous sinus (sinovenous) thrombosis in children. Neurosurg Clin N Am. 2010;21(3-5):511-527. doi:10.1016/j.nec.2010.03.006
  135. Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children. Circulation. 2003;108(11):1362-1367. doi:10.1161/01.CIR.0000087598.05977.45
  136. Sloan MA, Kittner SJ, Feeser BR, et al. Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology. 1998;50(6):1688-1693. doi:10.1212/wnl.50.6.1688
  137. Smith ER. 62 Ischemic stroke in the pediatric population. In: Principles and Practice of Pediatric Neurosurgery. 2nd ed. Georg Thieme Verlag KG; 2008. doi:10.1055/b-0034-56439
  138. Gelfand AA, Fullerton HJ, Jacobson A, et al. Is migraine a risk factor for pediatric stroke? Cephalalgia Int J Headache. 2015;35(14):1252-1260. doi:10.1177/0333102415576222
  139. Fouladi M, Langston J, Mulhern R, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol Off J Am Soc Clin Oncol. 2000;18(4):824-831. doi:10.1200/JCO.2000.18.4.824
  140. Johnson C, Darbari DS, Pergami P, et al. Moyamoya syndrome in children with sickle cell disease: a 10-year single-center experience. Blood. 2017;130(Supplement 1):3552. doi:10.1182/blood.V130.Suppl_1.3552.3552
  141. Dobson SR, Holden KR, Nietert PJ, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood. 2002;99(9):3144-3150. doi:10.1182/blood.v99.9.3144
  142. Marks LJ, Munube D, Kasirye P, et al. Stroke prevalence in children with sickle cell disease in Sub-Saharan Africa: a systematic review and meta-analysis. Glob Pediatr Health. 2018;5:2333794X18774970. doi:10.1177/2333794X18774970
  143. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth. 2002;16(6):752-765. doi:10.1053/jcan.2002.128436
  144. Moll S, Varga EA. Homocysteine and MTHFR mutations. Circulation. 2015;132(1):e6-e9. doi:10.1161/CIRCULATIONAHA.114.013311
  145. Torra R. Renal manifestations in Fabry disease and therapeutic options: New strategies to prevent cardiovascular risk in chronic kidney disease. Kidney Int. 2008;74:S29-S32. doi:10.1038/ki.2008.522
  146. Pieroni M, Moon JC, Arbustini E, et al. Cardiac involvement in Fabry disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77(7):922-936. doi:10.1016/j.jacc.2020.12.024
  147. Brandt T, Grond-Ginsbach C. Spontaneous cervical artery dissection. Stroke. 2002;33(3):657-658. doi:10.1161/str.33.3.657
  148. Weiss PF. Pediatric vasculitis. Pediatr Clin North Am. 2012;59(2):407-423. doi:10.1016/j.pcl.2012.03.013
  149. Bernaudin F, Verlhac S, Arnaud C, et al. Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia. Blood. 2015;125(10):1653-1661. doi:10.1182/blood-2014-09-599852
  150. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):385-390. doi:10.1067/mpd.2001.117580
  151. Switzer JA, Hess DC, Nichols FT, et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006;5(6):501-512. doi:10.1016/S1474-4422(06)70469-0
  152. Connes P, Verlhac S, Bernaudin F. Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. Br J Haematol. 2013;161(4):484-498. doi:10.1111/bjh.12300
  153. Mayne EW, Mailo JA, Pabst L, et al. Pediatric stroke and cardiac disease: challenges in recognition and management. Semin Pediatr Neurol. 2022;43:100992. doi:10.1016/j.spen.2022.100992
  154. Chung MG, Guilliams KP, Wilson JL, et al. Arterial ischemic stroke secondary to cardiac disease in neonates and children. Pediatr Neurol. 2019;100:35-41. doi:10.1016/j.pediatrneurol.2019.06.008
  155. Sinclair AJ, Fox CK, Ichord RN, et al. Stroke in children With cardiac disease: report from the International Pediatric Stroke Study Group Symposium. Pediatr Neurol. 2015;52(1):5-15. doi:10.1016/j.pediatrneurol.2014.09.016
  156. Mittal SO, ThatiGanganna S, Kuhns B, et al. Acute ischemic stroke in pediatric patients. Stroke. 2015;46(2). doi:10.1161/STROKEAHA.114.007681
  157. Giglia TM, Massicotte MP, Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease. Circulation. 2013;128(24):2622-2703. doi:10.1161/01.cir.0000436140.77832.7a
  158. Harrar DB, Salussolia CL, Vittner P, et al. Stroke after cardiac catheterization in children. Pediatr Neurol. 2019;100:42-48. doi:10.1016/j.pediatrneurol.2019.07.005
  159. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11(1):S56-S64. doi:10.1038/sj.cdd.4401451
  160. Kolodny E, Fellgiebel A, Hilz MJ, et al. Cerebrovascular involvement in Fabry disease. Stroke. 2015;46(1):302-313. doi:10.1161/STROKEAHA.114.006283
  161. Beslow LA, Jordan LC. Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations. Childs Nerv Syst. 2010;26(10):1263-1273. doi:10.1007/s00381-010-1208-9
  162. Ulivi L, Squitieri M, Cohen H, et al. Cerebral venous thrombosis: a practical guide. Pract Neurol. 2020;20(5):356-367. doi:10.1136/practneurol-2019-002415
  163. Lasjaunias P, ter Brugge KG, Berenstein A, eds. Cerebral venous thrombosis. In: Surgical Neuroangiography: Clinical and Interventional Aspects in Children. Springer; 2006:537-557. doi:10.1007/978-3-540-68320-9_10
  164. Inusa BPD, Hsu LL, Kohli N, et al. Sickle cell disease—genetics, pathophysiology, clinical presentation and treatment. Int J Neonatal Screen. 2019;5(2):20. doi:10.3390/ijns5020020
  165. Pierpont ME, Brueckner M, Chung WK, et al. Genetic basis for congenital heart disease: revisited: a scientific statement from the American Heart Association. Circulation. 2018;138(21). doi:10.1161/CIR.0000000000000606
  166. Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 2: Homocystinuria, organic acidurias, and urea cycle disorders. Arch Neurol. 2010;67(2):148-153. doi:10.1001/archneurol.2009.333
  167. El-Hattab AW, Adesina AM, Jones J, et al. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116(1):4-12. doi:10.1016/j.ymgme.2015.06.004
  168. Gdynia HJ, Kühnlein P, Ludolph AC, et al. Connective tissue disorders in dissections of the carotid or vertebral arteries. J Clin Neurosci. 2008;15(5):489-494. doi:10.1016/j.jocn.2007.10.001
  169. Smitka M, Bruck N, Engellandt K, et al. Clinical perspective on primary angiitis of the central nervous system in childhood (cPACNS). Front Pediatr. 2020;8:281. doi:10.3389/fped.2020.00281
  170. Espinoza JL, Ai S, Matsumura I. New insights on the pathogenesis of Takayasu arteritis: revisiting the microbial theory. Pathogens. 2018;7(3):73. doi:10.3390/pathogens7030073
  171. Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7):391-405. doi:10.1038/s41584-020-0426-0
  172. Hara T, Yamamura K, Sakai Y. The up-to-date pathophysiology of Kawasaki disease. Clin Transl Immunol. 2021;10(5):e1284. doi:10.1002/cti2.1284
  173. Ozen S. The changing face of polyarteritis nodosa and necrotizing vasculitis. Nat Rev Rheumatol. 2017;13(6):381-386. doi:10.1038/nrrheum.2017.68
  174. Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-eate review. Front Immunol. 2021;12. Accessed September 11, 2023. https://www.frontiersin.org/articles/10.3389/fimmu.2021.771619
  175. Sokol DK, McIntyre JA, Short RA, et al. Henoch–Schönlein purpura and stroke: antiphosphatidyl-ethanolamine antibody in CSF and serum. Neurology. 2000;55(9):1379-1381. doi:10.1212/WNL.55.9.1379
  176. Yildiz M, Haslak F, Adrovic A, et al. Pediatric Behçet’s disease. Front Med. 2021;8:627192. doi:10.3389/fmed.2021.627192
  177. Mangla A, Ehsan M, Agarwal N, et al. Sickle cell anemia. In: StatPearls. StatPearls Publishing; 2024. Accessed July 7, 2024. http://www.ncbi.nlm.nih.gov/books/NBK482164/
  178. Gordon B, González-Fernández V, Dos-Subirà L. Myocardial fibrosis in congenital heart disease. Front Pediatr. 2022;10. doi:10.3389/fped.2022.965204
  179. Pezzini A, Del Zotto E, Archetti S, et al. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke. 2002;33(3):664-669. doi:10.1161/hs0302.103625
  180. de Menezes Neves PDM, Machado JR, Custódio FB, et al. Ultrastructural deposits appearing as “zebra bodies” in renal biopsy: Fabry disease?– comparative case reports. BMC Nephrol. 2017;18:157. doi:10.1186/s12882-017-0571-0
  181. Cheng W, Zhang Y, He L. MRI Features of stroke-like episodes in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. Front Neurol. 2022;13:843386. doi:10.3389/fneur.2022.843386
  182. Rodallec MH, Marteau V, Gerber S, et al. Craniocervical arterial dissection: spectrum of imaging findings and differential diagnosis. RadioGraphics. 2008;28(6):1711-1728. doi:10.1148/rg.286085512
  183. Aeschlimann FA, Twilt M, Yeung RSM. Childhood-onset Takayasu arteritis. Eur J Rheumatol. 2020;7(Suppl 1):S58-S66. doi:10.5152/eurjrheum.2019.19195
  184. Seki M, Minami T. Kawasaki disease: Pathology, risks, and management. Vasc Health Risk Manag. 2022;18:407-416. doi:10.2147/VHRM.S291762
  185. Wang L, Duan H, Zhou K, et al. Kawasaki disease complicated by late-onset fatal cerebral infarction: a case report and literature review. Front Pediatr. 2021;9:598867. doi:10.3389/fped.2021.598867
  186. Halabi C, Williams EK, Morshed RA, et al. Neurological manifestations of polyarteritis nodosa: a tour of the neuroaxis by case series. BMC Neurol. 2021;21(1):205. doi:10.1186/s12883-021-02228-2
  187. Rodrigues M, Amaral D, Barreira JL, et al. Childhood polyarteritis nodosa presenting as stroke and arterial hypertension. BMJ Case Rep. 2014;2014:bcr2014207866. doi:10.1136/bcr-2014-207866
  188. Pichard DC, Ombrello AK, Hoffmann P, et al. Early onset stroke, polyarteritis nodosa, and livedo racemosa. J Am Acad Dermatol. 2016;75(2):449-453. doi:10.1016/j.jaad.2016.01.057
  189. Zheng Y, Zhang Y, Cai M, et al. Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know. Front Neurol. 2019;9:1166. doi:10.3389/fneur.2018.01166
  190. Bérubé MD, Blais N, Lanthier S. Chapter 74 – Neurologic manifestations of Henoch–Schönlein purpura. In: Biller J, Ferro JM, eds. Handbook of Clinical Neurology. Vol 120. Neurologic Aspects of Systemic Disease Part II. Elsevier; 2014:1101-1111. doi:10.1016/B978-0-7020-4087-0.00074-7
  191. Costagliola G, Cappelli S, Consolini R. Behçet’s disease in children: diagnostic and management challenges. Ther Clin Risk Manag. 2020;16:495-507. doi:10.2147/TCRM.S232660
  192. Bourrienne MC, Loyau S, Benichi S, et al. A novel mouse model for cerebral venous sinus thrombosis. Transl Stroke Res. 2021;12(6):1055-1066. doi:10.1007/s12975-021-00898-1
  193. Billinghurst LL, Beslow LA, Abend NS, et al. Incidence and predictors of epilepsy after pediatric arterial ischemic stroke. Neurology. 2017;88(7):630-637. doi:10.1212/WNL.0000000000003603
  194. Tsze DS, Valente JH. Pediatric stroke: a review. Emerg Med Int. 2011;2011:734506. doi:10.1155/2011/734506
  195. Mackay MT, Yock-Corrales A, Churilov L, et al. Differentiating childhood stroke from mimics in the emergency department. Stroke. 2016;47(10):2476-2481. doi:10.1161/STROKEAHA.116.014179
  196. Shellhaas RA, Smith SE, O’Tool E, et al. Mimics of childhood stroke: characteristics of a prospective cohort. Pediatrics. 2006;118(2):704-709. doi:10.1542/peds.2005-2676
  197. Rafay MF, Pontigon AM, Chiang J, et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke. 2009;40(1):58-64. doi:10.1161/STROKEAHA.108.519066
  198. Braun KPJ, Kappelle LJ, Kirkham FJ, et al. Diagnostic pitfalls in paediatric ischaemic stroke. Dev Med Child Neurol. 2006;48(12):985-990. doi:10.1017/S0012162206002167
  199. Tierradentro-García LO, Zandifar A, Ullman NL, et al. Imaging of suspected stroke in children, from the AJR special series on emergency radiology. Am J Roentgenol. 2023;220(3):330-342. doi:10.2214/AJR.22.27816
  200. Mastrangelo M, Giordo L, Ricciardi G, et al. Acute ischemic stroke in childhood: a comprehensive review. Eur J Pediatr. 2022;181(1):45-58. doi:10.1007/s00431-021-04212-x
  201. Medley TL, Miteff C, Andrews I, et al. Australian Clinical Consensus Guideline: The diagnosis and acute management of childhood stroke. Int J Stroke Off J Int Stroke Soc. 2019;14(1):94-106. doi:10.1177/1747493018799958
  202. Stroke in childhood – clinical guideline for diagnosis, management and rehabilitation. RCPCH. Accessed October 1, 2023. https://www.rcpch.ac.uk/resources/stroke-in-childhood-clinical-guideline
  203. Elbers J, Wainwright MS, Amlie-Lefond C. The pediatric stroke code: early management of the child with stroke. J Pediatr. 2015;167(1):19-24.e1-4. doi:10.1016/j.jpeds.2015.03.051
  204. Ichord RN, Bastian R, Abraham L, et al. Inter-rater reliability of the Pediatric NIH Stroke Scale (PedNIHSS) in a multicenter study. Stroke J Cereb Circ. 2011;42(3):613-617. doi:10.1161/STROKEAHA.110.607192
  205. Klučka J, Klabusayová E, Musilová T, et al. Pediatric patient with ischemic stroke: initial approach and early management. Children. 2021;8(8):649. doi:10.3390/children8080649
  206. Reeves SL, Madden B, Freed GL, et al. Transcranial Doppler screening among children and adolescents with sickle cell anemia. JAMA Pediatr. 2016;170(6):550-556. doi:10.1001/jamapediatrics.2015.4859
  207. Khalaf A, Michael I, Fullerton H, et al. Pediatric stroke imaging. Pediatr Neurol. 2018;86:5-18. doi:10.1016/j.pediatrneurol.2018.05.008
  208. Shaban S, Huasen B, Haridas A, et al. Digital subtraction angiography in cerebrovascular disease: current practice and perspectives on diagnosis, acute treatment and prognosis. Acta Neurol Belg. 2022;122(3):763-780. doi:10.1007/s13760-021-01805-z/
  209. Hakimi R, Sivakumar S. Imaging of carotid dissection. Curr Pain Headache Rep. 2019;23(1):2. doi:10.1007/s11916-019-0741-9
  210. Canedo-Antelo M, Baleato-González S, Mosqueira AJ, et al. Radiologic clues to cerebral venous thrombosis. RadioGraphics. 2019;39(6):1611-1628. doi:10.1148/rg.2019190015
  211. Fan HC, Hu CF, Juan CJ, et al. Current proceedings of childhood stroke. Stroke Res Treat. 2011;2011:432839. doi:10.4061/2011/432839
  212. Allman C, Scott RB. Neuropsychological sequelae following pediatric stroke: a nonlinear model of age at lesion effects. Child Neuropsychol J Norm Abnorm Dev Child Adolesc. 2013;19(1):97-107. doi:10.1080/09297049.2011.639756
  213. O’Keeffe F, Liégeois F, Eve M, et al. CE Neuropsychological and neurobehavioral outcome following childhood arterial ischemic stroke: attention deficits, emotional dysregulation, and executive dysfunction. Child Neuropsychol. 2014;20(5):557-582. doi:10.1080/09297049.2013.832740
  214. Krivitzky LS, Westmacott R, Boada R, et al. Recent advances in neuropsychological outcomes and intervention in pediatric stroke. Stroke. 2022;53(12):3780-3789. doi:10.1161/STROKEAHA.122.037294
  215. Kossorotoff M, Kerleroux B, Boulouis G, et al. Recanalization treatments for pediatric acute ischemic stroke in France. JAMA Netw Open. 2022;5(9):e2231343. doi:10.1001/jamanetworkopen.2022.31343
  216. Berkhemer OA, Fransen PSS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20. doi:10.1056/NEJMoa1411587
  217. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11-21. doi:10.1056/NEJMoa1706442
  218. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708-718. doi:10.1056/NEJMoa1713973
  219. Rennert RC, Wali AR, Steinberg JA, et al. Epidemiology, natural history, and clinical presentation of large vessel ischemic stroke. Neurosurgery. 2019;85(Suppl 1):S4-S8. doi:10.1093/neuros/nyz042
  220. Lin N, Smith ER, Scott RM, et al. Safety of neuroangiography and embolization in children: complication analysis of 697 consecutive procedures in 394 patients. J Neurosurg Pediatr. 2015;16(4):432-438. doi:10.3171/2015.2.PEDS14431
  221. Saver JL. Intra-arterial thrombolysis. Neurology. 2001;57(suppl_2):S58-S60. doi:10.1212/WNL.57.suppl_2.S58
  222. Abou-Chebl A. Intra-arterial therapy for acute ischemic stroke. Neurotherapeutics. 2011;8(3):400-413. doi:10.1007/s13311-011-0059-8
  223. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA. 1999;282(21):2003-2011. doi:10.1001/jama.282.21.2003
  224. Lehman LL, DeVeber G, Pergami P, et al. Characteristics and outcome in children With craniectomy following acute ischemic stroke in the International Pediatric Stroke Study. J Child Neurol. 2019;34(12):765-769. doi:10.1177/0883073819855534
  225. Pallesen LP, Barlinn K, Puetz V. Role of decompressive craniectomy in ischemic stroke. Front Neurol. 2019;9:1119. doi:10.3389/fneur.2018.01119
  226. Beez T, Munoz-Bendix C, Steiger HJ, et al. Decompressive craniectomy for acute ischemic stroke. Crit Care. 2019;23(1):209. doi:10.1186/s13054-019-2490-x
  227. Lauzier DC, Galardi MM, Guilliams KP, et al. Pediatric thrombectomy. Stroke. 2021;52(4):1511-1519. doi:10.1161/STROKEAHA.120.032268
  228. Dinsmore J, Elwishi M, Kailainathan P. Anaesthesia for endovascular thrombectomy. BJA Educ. 2018;18(10):291-299. doi:10.1016/j.bjae.2018.07.001
  229. Talke PO, Sharma D, Heyer EJ, et al. Society for Neuroscience in Anesthesiology and Critical Care Expert consensus statement: anesthetic management of endovascular treatment for acute ischemic stroke*: endorsed by the Society of NeuroInterventional Surgery and the Neurocritical Care Society. J Neurosurg Anesthesiol. 2014;26(2):95. doi:10.1097/ANA.0000000000000042
  230. Kofke WA, Stiefel M. Monitoring and intraoperative management of elevated intracranial pressure and decompressive craniectomy. Anesthesiol Clin. 2007;25(3):579-603. doi:10.1016/j.anclin.2007.05.007
  231. Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333-341. doi:10.1016/S0140-6736(13)62038-3
  232. Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA. 2015;313(12):1240-1248. doi:10.1001/jama.2015.1693
  233. Gao P, Wang T, Wang D, et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: The CASSISS Randomized Clinical Trial. JAMA. 2022;328(6):534-542. doi:10.1001/jama.2022.12000
  234. Masang Ban Bolly H, Faried A, Laurens Jembise T, et al. The ideal selection criteria for duraplasty material in brain surgery: A review. Interdisciplinary Neurosurgery. 2020;22:100800. doi:10.1016/j.inat.2020.100800
  235. Cho YJ, Kang SH. Review of cranioplasty after decompressive craniectomy. Korean J Neurotrauma. 2017;13(1):9-14. doi:10.13004/kjnt.2017.13.1.9
  236. Lin J, Frontera JA. Decompressive hemicraniectomy for large hemispheric strokes. Stroke. 2021;52(4):1500-1510. doi:10.1161/STROKEAHA.120.032359
  237. Takeuchi S, Takasato Y, Masaoka H, et al. Hydrocephalus following decompressive craniectomy for ischemic stroke. Acta Neurochir Suppl. 2013;118:289-291. doi:10.1007/978-3-7091-1434-6_56
  238. Munich SA, Vakharia K, Levy EI. Overview of mechanical thrombectomy techniques. Neurosurgery. 2019;85(suppl_1):S60. doi:10.1093/neuros/nyz071
  239. Timofeev I, Santarius T, Kolias AG, et al. Decompressive craniectomy — operative technique and perioperative care. In: Pickard JD, Akalan N, Benes V, et al., eds. Advances and Technical Standards in Neurosurgery. Springer; 2012:115-136. doi:10.1007/978-3-7091-0676-1_6
  240. Al-Bayati AR, Nogueira RG, Samaniego EA, et al. Mechanical thrombectomy: techniques and hybrid approaches for recanalization. In: Samaniego EA, Hasan D, eds. Acute Stroke Management in the Era of Thrombectomy. Springer International Publishing; 2019:87-103. doi:10.1007/978-3-030-17535-1_8
  241. Turk AS, Spiotta A, Frei D, et al. Initial clinical experience with the ADAPT technique: a direct aspiration first pass technique for stroke thrombectomy. J Neurointerventional Surg. 2014;6(3):231-237. doi:10.1136/neurintsurg-2013-010713
  242. Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013;44(9):2650-2663. doi:10.1161/STROKEAHA.113.001972
  243. Anadani M, Orabi MY, Alawieh A, et al. Blood pressure and outcome after mechanical thrombectomy with successful revascularization. Stroke. 2019;50(9):2448-2454. doi:10.1161/STROKEAHA.118.024687
  244. Nathanson MH, Andrzejowski J, Dinsmore J, et al. Guidelines for safe transfer of the brain-injured patient: trauma and stroke, 2019. Anaesthesia. 2020;75(2):234-246. doi:10.1111/anae.14866
  245. Hernández-Durán S, Meinen L, Rohde V, et al. Invasive monitoring of intracranial pressure after decompressive craniectomy in malignant stroke. Stroke. 2021;52(2):707-711. doi:10.1161/STROKEAHA.120.032390
  246. Sauvigny T, Göttsche J, Czorlich P, et al. Intracranial pressure in patients undergoing decompressive craniectomy: new perspective on thresholds. J Neurosurg. 2017;128(3):819-827. doi:10.3171/2016.11.JNS162263
  247. Jadhav AP, Molyneaux BJ, Hill MD, et al. Care of the post-thrombectomy patient. Stroke. 2018;49(11):2801-2807. doi:10.1161/STROKEAHA.118.021640
  248. Langhorne P, Wu O, Rodgers H, et al. A very early rehabilitation trial after stroke (AVERT): a phase III, multicentre, randomised controlled trial. Health Technol Assess Winch Engl. 2017;21(54):1-120. doi:10.3310/hta21540
  249. Ng FC, Campbell BCV. Imaging after thrombolysis and thrombectomy: rationale, modalities and management implications. Curr Neurol Neurosci Rep. 2019;19(8):57. doi:10.1007/s11910-019-0970-7
  250. Ram BL, Rajesh S, George RK. Iatrogenic lower limb ischemia in children with congenital cardiac disease. Indian J Vasc Endovasc Surg. 2018;5(1):36. doi:10.4103/ijves.ijves_39_17
  251. Sun LR, Wilson JL, Waak M, et al. Tenecteplase in acute stroke: what about the children? Stroke. 2023;54(7):1950-1953. doi:10.1161/STROKEAHA.123.042951
  252. Wang L, Hao M, Wu N, et al. Comprehensive review of tenecteplase for thrombolysis in acute ischemic stroke. J Am Heart Assoc. 2024;13(9):e031692. doi:10.1161/JAHA.123.031692
  253. Menon SC, Grove A, McFadden M, et al. Clinical practice, resource utilization, and outcomes of device closure of patent foramen ovale in pediatrics. Pediatr Neurol. 2014;50(3):213-217. doi:10.1016/j.pediatrneurol.2013.11.007
  254. Mortimer AM, Bradley MD, O’Leary S, Renowden SA. Endovascular treatment of children with cerebral venous sinus thrombosis: a case series. Pediatr Neurol. 2013;49(5):305-312. doi:10.1016/j.pediatrneurol.2013.07.008
  255. Omoto K, Nakagawa I, Park HS, et al. Successful emergent endovascular mechanical thrombectomy for pediatric and young adult cerebral venous sinus thrombosis in coma. World Neurosurg. 2019;122:203-208. doi:10.1016/j.wneu.2018.10.189
  256. Johns Hopkins All Children’s Hospital childhood arterial Ischemic stroke clinical pathway. https://www.hopkinsmedicine.org/-/media/files/allchildrens/clinical-pathways/childhood-arterial-ischemic-stroke-clinical-pathway-8_20_2020.pdf
  257. Akins PT, Amar AP, Pakbaz RS, et al. Complications of endovascular treatment for acute stroke in the SWIFT Trial with solitaire and merci devices. AJNR Am J Neuroradiol. 2014;35(3):524-528. doi:10.3174/ajnr.A3707
  258. Dicpinigaitis AJ, Gandhi CD, Pisapia J, et al. Endovascular thrombectomy for pediatric acute ischemic stroke. Stroke. 2022;53(5):1530-1539. doi:10.1161/STROKEAHA.121.036361
  259. Ban SP, Son YJ, Yang HJ, et al. Analysis of complications following decompressive craniectomy for traumatic brain injury. J Korean Neurosurg Soc. 2010;48(3):244-250. doi:10.3340/jkns.2010.48.3.244
  260. Gopalakrishnan MS, Shanbhag NC, Shukla DP, et al. Complications of decompressive craniectomy. Front Neurol. 2018;9. doi:10.3389/fneur.2018.00977
  261. Fitzmaurice DA, Blann AD, Lip GYH. Bleeding risks of antithrombotic therapy. BMJ. 2002;325(7368):828-831.
  262. Amlie-Lefond C, Shaw DWW, Cooper A, et al. Risk of intracranial hemorrhage following intravenous tPA (tissue-type plasminogen activator) for acute stroke is low in children. Stroke. 2020;51(2):542-548. doi:10.1161/STROKEAHA.119.027225
  263. Smith R. Complications of therapy for ANCA-associated vasculitis. Rheumatol Oxf Engl. 2020;59(Suppl 3):iii74-iii78. doi:10.1093/rheumatology/kez618
  264. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol. 2001;38(1 Suppl 1):14-22. doi:10.1016/s0037-1963(01)90056-3
  265. Greenham M, Gordon A, Anderson V, et al. Outcome in childhood stroke. Stroke. 2016;47(4):1159-1164. doi:10.1161/STROKEAHA.115.011622
  266. Lanthier S, Carmant L, David M, et al. Stroke in children. Neurology. 2000;54(2):371-371. doi:10.1212/WNL.54.2.371
  267. Fox CK, Johnston SC, Sidney S, et al. High critical care usage due to pediatric stroke. Neurology. 2012;79(5):420-427. doi:10.1212/WNL.0b013e3182616fd7
  268. Goeggel Simonetti B, Cavelti A, Arnold M, et al. Long-term outcome after arterial ischemic stroke in children and young adults. Neurology. 2015;84(19):1941-1947. doi:10.1212/WNL.0000000000001555
  269. Mallick AA, Ganesan V, Kirkham FJ, et al. Outcome and recurrence 1 year after pediatric arterial ischemic stroke in a population-based cohort. Ann Neurol. 2016;79(5):784-793. doi:10.1002/ana.24626
  270. Ganesan V, Prengler M, Wade A, et al. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation. 2006;114(20):2170-2177. doi:10.1161/CIRCULATIONAHA.105.583690
  271. Fullerton HJ, Wu YW, Sidney S, et al. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics. 2007;119(3):495-501. doi:10.1542/peds.2006-2791
  272. Fullerton HJ, Wintermark M, Hills NK, et al. Risk of recurrent arterial ischemic stroke in childhood. Stroke. 2016;47(1):53-59. doi:10.1161/STROKEAHA.115.011173
  273. Westmacott R, Askalan R, Macgregor D, et al. Cognitive outcome following unilateral arterial ischaemic stroke in childhood: effects of age at stroke and lesion location. Dev Med Child Neurol. 2010;52(4):386-393. doi:10.1111/j.1469-8749.2009.03403.x
  274. Ravindra VM, Alexander M, Taussky P, et al. Endovascular thrombectomy for pediatric acute ischemic stroke: a multi-institutional experience of technical and clinical outcomes. Neurosurgery. 2020;88(1):46-54. doi:10.1093/neuros/nyaa312
  275. Cobb MIPH, Laarakker AS, Gonzalez LF, et al. Endovascular therapies for acute ischemic stroke in children. Stroke. 2017;48(7):2026-2030. doi:10.1161/STROKEAHA.117.016887
  276. Carlhan-Ledermann A, Bartoli A, Gebistorf F, et al. Decompressive hemicraniectomy in pediatric malignant arterial ischemic stroke: a case-based review. Childs Nerv Syst. 2023;39(9):2377-2389. doi:10.1007/s00381-023-06086-w
  277. Janjua N, Nasar A, Lynch JK, et al. Thrombolysis for ischemic stroke in children. Stroke. 2007;38(6):1850-1854. doi:10.1161/STROKEAHA.106.473983
  278. Kirton A, Jordan LC. Stroke in children: key advances in the field and the next 20 years. Stroke. 2024;55(1):182-185. doi:10.1161/STROKEAHA.123.044250
  279. Lehman LL, Beslow LA, Steinlin M, et al. What will improve pediatric acute stroke care? Stroke. 2019;50(2):249-256. doi:10.1161/STROKEAHA.118.022881
  280. Sun LR, Lynch JK. Advances in the diagnosis and treatment of pediatric arterial ischemic stroke. Neurotherapeutics. 2023;20(3):633-654. doi:10.1007/s13311-023-01373-5
  281. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346(8983):1133-1134. doi:10.1016/s0140-6736(95)91803-5
  282. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost. 1998;79(4):706-708.
  283. Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104. Published 2010 Nov 2. doi:10.1038/ncomms1104
  284. Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 2013;381(9861):142-151. doi:10.1016/S0140-6736(12)61229-X
  285. GBD 2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021 [published correction appears in Lancet Haematol. 2023 Aug;10(8):e574. doi: 10.1016/S2352-3026(23)00215-6]. Lancet Haematol. 2023;10(8):e585-e599. doi:10.1016/S2352-3026(23)00118-7
  286. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512-S521. doi:10.1016/j.amepre.2009.12.022
  287. Kirkham FJ, Lagunju IA. Epidemiology of Stroke in Sickle Cell Disease. J Clin Med. 2021;10(18):4232. Published 2021 Sep 18. doi:10.3390/jcm10184232
  288. Liu Y, Chen S, Zühlke L, et al. Global prevalence of congenital heart disease in school-age children: a meta-analysis and systematic review. BMC Cardiovasc Disord. 2020;20(1):488. Published 2020 Nov 19. doi:10.1186/s12872-020-01781-x
Evaluation of Ischemic Cerebrovascular Disease in Children
Intracranial Aneurysms in Children Homepage